Literature DB >> 33135529

Rare intraspinal clear cell meningioma in children: a case report and literature review.

Zheng Hao1,2, Si Hu1, Nian-Zu Yu1.   

Abstract

Meningioma of the spinal canal is very rare. Clear cell meningioma (CCM) with special histological features occurs more commonly in the spinal cord. A review of the published English-language literature identified 40 reported cases of children with intraspinal CCM and this current report presents an additional case of a 3-year-old child with confirmed lumbar CCM. The current case underwent gross total resection of the CCM. At 9 months after the operation, lumbar magnetic resonance imaging was undertaken and confirmed the absence of tumour recurrence. The child was able to walk normally again. During this period, the child did not receive adjuvant treatments such as radiotherapy and chemotherapy. An evaluation of the 41 cases demonstrated the following: (i) there was no significant difference between the recurrence rate of females and males; (ii) there was a significant difference in the recurrence rate based on the extent of resection (gross total resection versus partial resection); (iii) the recurrence rate in patients where the number of involved segments ≥3 levels was significantly higher than that in patients where the number of involved segments was 1-2 levels. For children with CCM, complete surgical resection might be an important characteristic for predicting the risk of the recurrence of CCM.

Entities:  

Keywords:  Clear cell meningioma; cerebrospinal fluid metastases; recurrence; spinal canal

Mesh:

Year:  2020        PMID: 33135529      PMCID: PMC7780564          DOI: 10.1177/0300060520952266

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


Introduction

Intraspinal meningioma is rare, and its subtype clear cell meningiomas (CCM), is even rarer.[1] CCM has a unique histological feature and is described as a polygonal cell with clear cytoplasm, possibly associated with its higher glycine content.[1] Although surgery is the main approach for CCM, it is associated with local recurrence and/or cerebrospinal fluid metastasis, which are major challenges during the treatment of CCM.[2] Of particular concern are children with CCMs in the spinal canal. A review of the literature identified 40 cases of CCM reported to date.[2-29] Worldwide, CCMs in the spinal canal are rare in children.[3] This current case report describes a 3-year-old child treated for CCM of the spinal canal and reviews the currently available literature.

Case report

A 3-year-old girl had pain in her thighs for more than 2 months, but she remained active and her parents did not seek medical attention. Then, 1 month later, she began having difficulty walking. Her symptoms gradually worsened so she was admitted to the Department of Neurosurgery, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China on 8 March 2019. After admission, a physical examination did not reveal any neurological deficits. Magnetic resonance imaging (MRI) showed an oval-shaped mass of undetermined nature measuring approximately 3 cm in the horizontal position of L2 in the spinal canal (Figure 1). No other spinal lesions were observed. A schwannoma was suspected. The child was prepared for surgery and an L2 laminoplasty was performed. The tumour was completely removed during the operation. After the operation, the pain in both of her legs had subsided and she was able to walk again. Staining of tumour specimens was positive for parakeratin. At 9 months after the operation, the patient had a follow-up lumbar MRI (Figure 2) and no tumour recurrence was observed. The patient could walk normally. During this period, the child did not receive adjuvant treatments such as radiotherapy and chemotherapy.
Figure 1.

Representative magnetic resonance imaging (MRI) scans showing an oval-shaped mass of undetermined nature, measuring approximately 3 cm in the spinal canal, in the horizontal position of L2 in a 3-year-old girl that had pain in her thighs for more than 3 months and had difficulty walking when she was admitted for assessment and diagnosis. No other spinal lesions were observed. (a) Sagittal T1 and (b) sagittal T2-weighted MRI images; (c) sagittal and axial (d) enhanced MRI images.

Figure 2.

Representative postoperative magnetic resonance imaging (MRI) scans in a 3-year-old girl that had pain in her thighs for more than 3 months and had difficulty walking when she was admitted for assessment and diagnosis. No tumour recurrence was observed. (a) Sagittal T1 and (b) sagittal T2-weighted MRI images on the third day after surgery; (c) sagittal T1 and (d) sagittal T2-weighted MRI images at 9 months after surgery.

Representative magnetic resonance imaging (MRI) scans showing an oval-shaped mass of undetermined nature, measuring approximately 3 cm in the spinal canal, in the horizontal position of L2 in a 3-year-old girl that had pain in her thighs for more than 3 months and had difficulty walking when she was admitted for assessment and diagnosis. No other spinal lesions were observed. (a) Sagittal T1 and (b) sagittal T2-weighted MRI images; (c) sagittal and axial (d) enhanced MRI images. Representative postoperative magnetic resonance imaging (MRI) scans in a 3-year-old girl that had pain in her thighs for more than 3 months and had difficulty walking when she was admitted for assessment and diagnosis. No tumour recurrence was observed. (a) Sagittal T1 and (b) sagittal T2-weighted MRI images on the third day after surgery; (c) sagittal T1 and (d) sagittal T2-weighted MRI images at 9 months after surgery. The histopathological results (Figure 3) were assessed by a pathologist at the First Affiliated Hospital of Nanchang University and by a histopathological diagnosis centre in Shanghai. The tumour was identified as a CCM. Tumour samples were stained for the relevant histopathological markers. Periodic acid-Schiff (PAS) staining was positive and immunostaining for Ki-67 showed a positive reaction with a labelling index of 20%. Immunohistochemical staining for parakeratin, vimentin, epithelial membrane antigen (EMA), progesterone receptor (PR), podoplanin (D2-40) and E-cadherin was also positive.
Figure 3.

Representative photomicrograph showing the histopathological findings from a sample of the tumour taken from a 3-year-old girl that had pain in her thighs for more than 3 months and had difficulty walking when she was admitted for assessment and diagnosis. The histology showed sheets of polygonal tumour cells with round or ovoid nuclei and clear cytoplasm. The tissue section was stained with haematoxylin and eosin stain. Scale bar 100 µm. The colour version of this figure is available at: http://imr.sagepub.com.

Representative photomicrograph showing the histopathological findings from a sample of the tumour taken from a 3-year-old girl that had pain in her thighs for more than 3 months and had difficulty walking when she was admitted for assessment and diagnosis. The histology showed sheets of polygonal tumour cells with round or ovoid nuclei and clear cytoplasm. The tissue section was stained with haematoxylin and eosin stain. Scale bar 100 µm. The colour version of this figure is available at: http://imr.sagepub.com. The parents of the patient provided written informed consent for the submission of this case report to the journal.

Discussion

Clear cell meningiomas are a rare subtype of meningioma that account for only 0.2–0.8% of meningiomas.[1,2] In terms of their histopathological features, CCMs are described as polygonal cells with a clear cytoplasm.[30] They are characterized by early local recurrence and cerebrospinal fluid metastasis. The World Health Organization defines CCM as grade II cancer. The incidence of CCM in children is higher than that in adults.[3] The main symptoms are caused by compression of the parietal nerve.[31] On imaging, CCM often has an apparent dural tail sign,[26] which is most commonly seen in meningiomas. As part of this case report, the electronic databases PubMed® and Embase® were searched from inception to 1 May 2020 using the key words “meningioma” and “clear cell” in order to identify all other cases reported in the English-language literature. The inclusion criteria for cases of paediatric spinal CCM were as follows: (i) the cases were newly diagnosed spinal CCMs; (ii) the patient was <18 years; (iii) clinical characteristics, treatment process and clinical outcome of spinal CCM could be obtained. All statistical analyses of the baseline patient characteristics were performed using Prism 5.0 software (GraphPad Software, San Diego, CA, USA) with categorical data compared with χ2-test or Fisher’s exact test. A P-value < 0.05 was considered statistically significant. Based on the inclusion criteria, a total of 41 paediatric patients with spinal CCMs including this current case were identified.[2-29] The characteristics of the 41 included cases are presented in Table 1 and Figure 4.[2-29]An evaluation of the 40 cases demonstrated the following: (i) there was no significant difference between the recurrence rate of females and males (nine of 29 [31.0%] versus four of 11 [36.4%], respectively); (ii) there was a significant difference in the recurrence rate based on extent of resection (gross total resection versus partial resection: nine of 36 [25.0%] versus four of four [100.0%], respectively; P = 0.002); (iii) the recurrence rate in patients with the number of involved segments ≥3 levels was significantly higher than that in patients with the number of involved segments was 1–2 levels (12 of 19 [63.2%] versus one of 20 [5.0%], respectively; P < 0.001) (Table 2). The data collected from this current literature review demonstrated that CCM can occur in children as young as 1-year-old, suggesting that CCM might develop even earlier, possibly during the growth of the spinal cord in embryonic development. CCM appears to be more common in girls and most cases of CCM reported to date occurred in the thoracic and lumbar spinal cords, rather than the cervical and temporal segments.
Table 1.

Clinical summary of 41 cases of paediatric intraspinal clear cell meningioma reported in the published literature including the present case.[2–29]

First authorAge, yearsSexTumour locationOperationRTRecurrence/months
Zorludemir 1995[2]9FL3–L5GTRNoYes/6
Zorludemir 1995[2]17FL4–L5GTRNoNo
Balogun 2013[3]3ML2–L5GTRNoYes/9
Carra 2003[4]2MT1–-L4GTRNoYes/60
Cho 2003[5]17FS1GTRNoNA
Colen 2009[6]13FL4–L5GTRYesNo
Douya 2001[7]5FT11–L5GTRNoNo
Dubois 1998[8]10FL1–L4GTRNoYes/6
Evans 2015[9]3ML1–L2GTRNoNo
Greene 2008[10]3FCervical spineGTRNoNo
Heth 2000[11]7FL4–L5GTRNoNo
Jallo 2001[12]2FC3–C5PRNoYes/5
Jallo 2001[12]8FL3–L5GTRNoYes/6
Kawasaki 2020[13]8FL3GTRNoNo
Li 2016[14]4MT11–T12GTRNoNo
Li 2016[14]7FT11–L1GTRNoNo
Li 2016[14]7FL2–L4GTRNoNo
Li 2019[15]15FL3GTRNoNo
Li 2019[15]16ML5–S1GTRNoNo
Li 2019[15]16FT11–L1PRYesYes/120
Li 2019[15]14FL4PRYesYes/24
Liu 2005[16]2MT10–L1GTRNoYes/60
Inoue 2018[17]5ML5GRTNoNo
Matsui, 1998[18]9FT11–T12, L2, L4–L5PRNoYes/4
Tunon-Pitalua 2011[19]17FL5–S1GTRNoNo
Murakami 2001[20]10FT12–L1, L2–L3GTRNoNo
Oviedo 2005[21]7ML2–L3GTRNoNo
Park 2000[22]1FT12–L2GTRNoYes/8
Present case3FL2GTRNoNo
Smith 2017[23]10FL1–L2GTRNoNo
Tauziede-Espariat 2018[24]13FC4–C5GTRNoNo
Vural 2007[25]4FC1–C2GTRNoNo
Wang 2014[26]18MC6–T2GTRNoYes/18
Wu 2017[27]14MC1–C2GTRNoNo
Wu 2017[27]7FL2–L4GTRNoNo
Wu 2017[27]16FT6–T7GTRNoNo
Wu 2019[28]7FT11–L1GTRNoNo
Wu 2019[28]7FL2–L4GTRNoNo
Wu 2019[28]4MT11–12GTRNoNo
Wu 2019[28]16FT12–L1GTRNoNo
Yu 2002[29]1FT12–L2GTRNoYes/8

RT, radiotherapy; GTR, gross total resection; PR, partial resection.

Figure 4.

Age and sex distribution (a) and tumour location (b) of 41 cases of paediatric intraspinal clear cell meningioma reported in the published literature including the present case.[2–29] The colour version of this figure is available at: http://imr.sagepub.com.

Table 2.

Baseline characteristics of paediatric patients including the present case (n = 40) with spinal clear cell meningioma identified in the published literature stratified according to recurrence.[2–4,6–29]

CharacteristicRecurrence group n = 13Non-recurrence group n = 27Statistical analysisa
SexNS
 Female9 (69.2)20 (74.1)
 Male4 (30.8)7 (25.9)
Extent of resectionP = 0.002
 Gross total resection9 (69.2)27 (100.0)
 Partial resection4 (30.8)0 (0.0)
Number of involved segmentsbP < 0.001
 1–2 levels1 (7.7)19 (73.1)
 ≥3 levels12 (92.3)7 (26.9)

Data presented as n of patients (%).

aBetween-group comparison; Fisher's exact test; NS, no significant difference (P ≥ 0.05).

bData regarding involved segments were not available for one case in the non-recurrence group.

Clinical summary of 41 cases of paediatric intraspinal clear cell meningioma reported in the published literature including the present case.[2-29] RT, radiotherapy; GTR, gross total resection; PR, partial resection. Age and sex distribution (a) and tumour location (b) of 41 cases of paediatric intraspinal clear cell meningioma reported in the published literature including the present case.[2-29] The colour version of this figure is available at: http://imr.sagepub.com. Baseline characteristics of paediatric patients including the present case (n = 40) with spinal clear cell meningioma identified in the published literature stratified according to recurrence.[2-4,6-29] Data presented as n of patients (%). aBetween-group comparison; Fisher's exact test; NS, no significant difference (P ≥ 0.05). bData regarding involved segments were not available for one case in the non-recurrence group. For tumours in the spinal canal, radical resection is the best treatment, but high recurrence rates affect quality of life, particularly in children.[3] A previous study proposed that the extent of resection is an important factor when predicting the recurrence of CCM and complete resection is important.[31] However, another study reported that despite gross total resection of the tumour, the recurrence rate was as high as 63%.[16] In the cases reviewed in the current report (Table 1), four tumours were partially resected and each experienced recurrence within 120 months; two of them within 4–5 months. The remaining 37 patients underwent a gross total resection and nine of them experienced recurrence. The time to recurrence ranged from 6 months to 5 years. Patients that did not experience recurrence may have needed longer follow-up durations. A report of one patient that underwent postoperative radiotherapy after total tumour resection demonstrated no tumour recurrence at a 2-year follow-up.[6] It is possible that radiotherapy reduces the recurrence rate of CCM. Controversially, one study did not recommend adjuvant radiotherapy for patients that underwent gross total resection because of the risk that radiotherapy might damage the spinal cord or other organs of paediatric patients.[8] For this reason, the present case did not undergo radiotherapy or other kinds of adjuvant therapy. At 9 months after the operation, the present case had a follow-up lumbar MRI (Figure 2), which confirmed that there was no tumour recurrence. The patient was also able to walk normally. Therefore, is postoperative radiotherapy necessary for these patients? This current case will continue to be observed in order to determine their prognosis over a longer period of time. The use of Ki-67 staining has been recommended to predict the recurrence rate of CCM.[13] In this previous case, the Ki-67 labelling index was 26% and no recurrence of CCM was observed at the 2-year follow-up.[13] However, some references describe the role of Ki-67 in the recurrence of CCM.[2,13] In this current case, the Ki-67 labelling index was 20%. Similarly, tumour samples from the current case were stained for the relevant histopathological markers, including vimentin, EMA, PR, D2-40, E-Cadherin and PAS to predict the recurrence of CCM. Future studies should have longer follow-up times and a larger number of patients. In conclusion, CCM should be considered a possibility when diagnosing meningiomas of the spinal canal, particularly in children. When pathological evidence is not clear, physicians should consider CCM. Knowing the high recurrence rate of CCM, more attention should be paid to ensure gross total resection is achieved. The establishment of relevant indicators for predicting recurrence risks and determining whether postoperative radiotherapy is necessary.
  28 in total

1.  Clear cell meningioma in a 22-month-old male: update after five years.

Authors:  Sabina Carrà; Paola Drigo; Marina Gardiman; Giorgio Perilongo; Luca Rigobello
Journal:  Pediatr Neurosurg       Date:  2003-03       Impact factor: 1.162

2.  Clear-cell meningioma of the cauda equina.

Authors:  A Dubois; A Sévely; S Boetto; M B Delisle; C Manelfe
Journal:  Neuroradiology       Date:  1998-11       Impact factor: 2.804

Review 3.  Intraspinal clear cell meningioma: diagnosis and management: report of two cases.

Authors:  G I Jallo; K F Kothbauer; V M Silvera; F J Epstein
Journal:  Neurosurgery       Date:  2001-01       Impact factor: 4.654

4.  Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.

Authors:  Arnault Tauziede-Espariat; Béatrice Parfait; Aurore Besnard; Joëlle Lacombe; Johan Pallud; Sanaa Tazi; Stéphanie Puget; Guillaume Lot; Benoît Terris; Joëlle Cohen; Michel Vidaud; Dominique Figarella-Branger; Franck Monnien; Marc Polivka; Homa Adle-Biassette; Pascale Varlet
Journal:  Brain Pathol       Date:  2017-06-12       Impact factor: 6.508

Review 5.  Spinal clear cell meningioma in a 3-year-old: a case report.

Authors:  James A Balogun; William Halliday; Eric Bouffet; Abhaya V Kulkarni
Journal:  Pediatr Neurosurg       Date:  2014-11-01       Impact factor: 1.162

6.  [Intra-spinal clear cell meningioma. Case report and literature review].

Authors:  M C Tuñón-Pitalúa; O Molina-Olier; G Alcalá-Cerra; L M Niño-Hernández; C F Lozano-Tangua
Journal:  Neurocirugia (Astur)       Date:  2011-02       Impact factor: 0.553

7.  Clinical features and long-term outcomes of pediatric spinal meningiomas.

Authors:  Liang Wu; Chenlong Yang; Tie Liu; Jingyi Fang; Jun Yang; Yulun Xu
Journal:  J Neurooncol       Date:  2017-04-21       Impact factor: 4.130

Review 8.  Meningiomas in children.

Authors:  Stephanie Greene; Nathan Nair; Jeffrey G Ojemann; Richard G Ellenbogen; Anthony M Avellino
Journal:  Pediatr Neurosurg       Date:  2007-12-14       Impact factor: 1.162

9.  Clear cell meningioma: clinical features, CT, and MR imaging findings in 23 patients.

Authors:  Xiao-Qiang Wang; Ming-Zhu Huang; Hua Zhang; Feng-Bing Sun; Bang-Bao Tao; Bao-Hui Feng; Chen-Long Liao; Ryan Kochanski; Xu-Ming Hua; Shi-Ting Li
Journal:  J Comput Assist Tomogr       Date:  2014 Mar-Apr       Impact factor: 1.826

10.  Clear-cell meningioma: CT and MR imaging findings in two cases involving the spinal canal and cerebellopontine angle.

Authors:  Ki Bong Yu; Myung Kwan Lim; Hyung Jin Kim; Chang Hae Suh; Hyung Chun Park; Eun Young Kim; Hye Seung Han
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.